Database: CanServ Services Compilation (European Union): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 12: Line 12:
'''Cancer Areas of Interest:''' [[hasCancerType::C00-D48: All neoplasms]].
'''Cancer Areas of Interest:''' [[hasCancerType::C00-D48: All neoplasms]].


'''Data access:''' [[dataAvailability::not publicly available]]. Catalog of services can be accessed. [https://directory.canserv.eu/#/catalogue Click here to access.]. Instructions on how to access services are available. [
'''Data access:''' [[dataAvailability::not publicly available]]. Catalog of services can be accessed. [https://directory.canserv.eu/#/catalogue Click here to access.].


'''Contact information:''' [https://www.canserv.eu/#contact Click here to learn more].
'''Contact information:''' [https://www.canserv.eu/#contact Click here to learn more].

Revision as of 21:48, 1 July 2024

Go back to European Union page

Type of database: services.

Primary purpose: canSERV is a European initiative dedicated to offering cutting-edge and customized cancer research services, enabling innovative R&D projects, fostering precision medicine, and establishing a sustainable network of research infrastructures to benefit the cancer research community and patients across Europe.

Sponsor, manager or home institution: canSERV.

Type of information: CanSERV offers a database of services researchers can employ, including Disease Models; Advanced Technologies for Personalised Oncology; Biomarker Research, Development, and Validation; Disease Models; New Therapeutic Solutions; Accelerated Translation into Personalised Oncology Clinical Practice; Open Digital Research Services; Disease Models Access to human samples and data; Planning and design of complex clinical trials; Training; Ethical, legal and socio-economic (ELSI) dimensions.

Cancer Areas of Interest: C00-D48: All neoplasms.

Data access: not publicly available. Catalog of services can be accessed. Click here to access..

Contact information: Click here to learn more.